Uterine Prolapse Surgery in India
Get Uterine Prolapse Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Uterine Prolapse Surgery in UAE
Uterine Prolapse Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Uterine prolapse surgery encompasses a spectrum of reconstructive and obliterative pelvic floor procedures designed to restore normal anatomical support to the uterus and vaginal vault, achieving symptom resolution in 85–95% of appropriately selected patients. GAF Healthcare facilitates access to board-certified urogynecologists and pelvic reconstructive surgeons at NABH- and JCI-accredited hospitals in India and JCI- and DHA-licensed centres in Dubai and Abu Dhabi, where advanced robotic-assisted and laparoscopic sacrocolpopexy techniques are routinely performed. International patients choose India and the UAE through GAF Healthcare for a combination of world-class surgical expertise, significantly reduced out-of-pocket costs, and seamless end-to-end care coordination from first consultation through post-operative follow-up.
Hospital Stay: 2–5 days (varies by procedure: 2–3 days for minimally invasive laparoscopic/robotic repair; 4–5 days for open abdominal or combined procedures) • Total Stay in Country (Fit-to-Fly): 3–6 weeks (minimally invasive approach: cleared for short-haul flight at ~3 weeks with compression stockings and DVT prophylaxis; open/complex repair: 5–6 weeks; final clearance confirmed by treating surgeon) • Success Rate: 85–95% (anatomical and symptomatic success at 1–2 years; robotic sacrocolpopexy achieves objective cure rates of 90–95% in high-volume centres)
What Is It?
Uterine prolapse occurs when the structural integrity of the pelvic floor — comprising the levator ani muscle complex, endopelvic fascia, and uterosacral-cardinal ligament system — is compromised to the degree that the uterus descends into or beyond the vaginal canal. Graded using the validated Pelvic Organ Prolapse Quantification (POP-Q) system from Stage I (above the hymen) to Stage IV (complete procidentia), symptomatic prolapse typically becomes surgically relevant at Stage II or above. Pathophysiological contributors include obstetric trauma (particularly multiparity and prolonged second-stage labour), collagen deficiency disorders, oestrogen depletion post-menopause, chronic elevated intra-abdominal pressure (obesity, chronic cough, constipation), and prior pelvic surgery. The physiological consequences extend beyond the uterus itself, frequently involving concomitant cystocele (anterior wall prolapse causing urinary retention or stress urinary incontinence) and rectocele (posterior wall prolapse causing obstructed defaecation), necessitating a comprehensive multi-compartment surgical approach.
The standard of care for symptomatic uterine prolapse refractory to pelvic floor physiotherapy and pessary management is surgical reconstruction. Contemporary guidelines from the International Urogynecological Association (IUGA) and the American Urogynecological Society (AUGS) favour uterine-sparing apical suspension procedures — such as laparoscopic or robotic sacrohysteropexy — in women who wish to preserve fertility, while vaginal hysterectomy with concurrent vault suspension (McCall culdoplasty, uterosacral ligament suspension, or sacrospinous ligament fixation) remains the most widely performed option in post-reproductive women. The evidence base from PROSPECT, OPTIMAL, and eVAULT randomised controlled trials informs modern surgical decision-making, with robotic-assisted sacrocolpopexy now regarded as the benchmark apical repair in high-volume academic centres.
Leading hospitals in India (Medanta, Apollo, Fortis, Max Super Speciality, Kokilaben Dhirubhai Ambani) and the UAE (Cleveland Clinic Abu Dhabi, American Hospital Dubai, Mediclinic City Hospital, King's College Hospital Dubai) maintain dedicated pelvic floor units staffed by fellowship-trained urogynecologists with annual surgical volumes exceeding 150–300 prolapse cases. Intraoperative urodynamics, 3D endoanal/endovaginal ultrasound, and robotic da Vinci Xi platforms are standard infrastructure at these centres, enabling precise intraoperative decision-making and reproducibly excellent anatomical outcomes.
Candidates
• ELIGIBLE PATIENTS:
• Women with symptomatic uterine prolapse classified as POP-Q Stage II–IV who have failed or declined conservative management (structured pelvic floor physiotherapy for ≥3–6 months; optimised pessary therapy)
• Patients with bothersome bulge symptoms, urinary dysfunction (retention, urgency, stress incontinence), obstructed defaecation, sexual dysfunction, or pelvic pain attributable to prolapse
• Women with concurrent anterior compartment defect (cystocele) or posterior compartment defect (rectocele) requiring combined multi-compartment repair
• Post-menopausal women with Stage III–IV prolapse (most common surgical group)
• Pre-menopausal or perimenopausal women desiring uterine preservation (sacrohysteropexy preferred)
• Patients with recurrent prolapse after prior native-tissue repair who may benefit from mesh-augmented or robotic-assisted reconstruction
• Medical fitness: ASA Physical Status I–III; BMI ideally <35 kg/m² (higher BMI patients evaluated case-by-case with anaesthesia team)
• REQUIRED PRE-OPERATIVE DIAGNOSTICS:
• POP-Q examination by specialist urogynecologist (mandatory staging)
• Multichannel urodynamic study (UDS): filling cystometry + pressure-flow study to identify occult stress urinary incontinence, detrusor overactivity, or voiding dysfunction
• Pelvic MRI (3 Tesla): delineates multi-compartment defects, levator ani integrity (avulsion injury), and relationship of prolapse to adjacent structures
• Transvaginal / transperineal ultrasound: dynamic assessment of levator hiatus area and puborectalis integrity
• Renal tract ultrasound ± urine culture: rule out hydronephrosis secondary to ureteric kinking in severe prolapse
• Full blood count, coagulation screen (PT/INR, aPTT), metabolic panel (renal and liver function), HbA1c in diabetic patients
• ECG and cardiopulmonary assessment for general anaesthesia clearance (echocardiogram if cardiac history)
• Cervical smear (Pap test) and endometrial sampling if abnormal uterine bleeding is present
• DVT risk stratification (Caprini Score): impacts anaesthesia and perioperative anticoagulation planning
• CONTRAINDICATIONS / CAUTION:
• Active pelvic or vaginal infection (must be treated and resolved before surgery)
• Unresolved abnormal uterine bleeding without histological evaluation
• Suspected or confirmed gynaecological malignancy (cervical, endometrial, ovarian) — oncological management takes priority
• Severe cardiopulmonary disease precluding general or regional anaesthesia (ASA IV–V)
• Uncontrolled diabetes (HbA1c >9%) — optimise before elective surgery
• Active anticoagulation therapy requiring bridging protocol (increased surgical risk; discuss with haematologist)
• Desire for future pregnancy is a relative contraindication to sacrocolpopexy with mesh and to hysterectomy-based repair; thorough counselling required
• Prior pelvic radiation (relative contraindication to synthetic mesh; native-tissue or biological graft repair preferred)
Procedure
CONSERVATIVE (NON-SURGICAL) APPROACHES — Baseline Before Surgery:
• Pelvic floor muscle training (PFMT): supervised physiotherapy with biofeedback, targeting levator ani strength; effective for Stage I–II and as surgical preamble to improve tissue quality
• Vaginal pessary therapy: silicone ring, Gellhorn, or cube pessary fitted by specialist; achieves symptom control in ~60% of women, particularly elderly or surgically unfit patients; requires 3–6 monthly review
• Topical oestrogen therapy: low-dose vaginal oestradiol (cream or pessary) in post-menopausal women to improve vaginal epithelial quality and tissue tensile strength prior to surgery
SURGICAL PROCEDURES — Native Tissue Repairs (Vaginal Route):
• Vaginal Hysterectomy with Vault Suspension: Removal of the uterus through the vaginal route followed by apical support reconstruction. Concomitant vault suspension techniques include:
• McCall Culdoplasty: Intraoperative plication of uterosacral ligaments to the vaginal cuff; reduces vault prolapse recurrence
• Uterosacral Ligament Suspension (USLS): Bilateral suture fixation of the vaginal cuff to the high uterosacral ligaments at the level of the ischial spine; OPTIMAL trial evidence supports equivalent long-term outcomes to sacrospinous fixation
• Sacrospinous Ligament Fixation (SSLF / Richter Procedure): Unilateral or bilateral fixation of the vaginal cuff to the sacrospinous ligament using permanent or delayed-absorbable sutures (or suture-capture devices such as Capio); well-evidenced for long-term apical support
• Anterior Colporrhaphy: Midline plication of pubocervical fascia for cystocele correction; performed concomitantly with apical repair
• Posterior Colporrhaphy with Perineorrhaphy: Site-specific or midline fascial repair for rectocele and perineal descent
• Colpocleisis (Le Fort Procedure): Obliterative procedure for elderly, sexually inactive women with severe prolapse and high surgical risk; partial colpocleisis for post-hysterectomy vault prolapse; highly effective (success rate >95%) with low morbidity
SURGICAL PROCEDURES — Uterine-Sparing Approaches:
• Laparoscopic Sacrohysteropexy: Mesh attachment from the uterine cervix/isthmus to the sacral promontory (S1–S2 anterior longitudinal ligament) via laparoscopy; preserves the uterus; suitable for younger women; 5-year anatomical success ~85–90%
• Manchester (Fothergill) Repair: Amputation of the cervix + anterior colporrhaphy + posterior repair; traditional uterine-sparing vaginal procedure; appropriate where elongated cervix is a primary component of the prolapse
• Hysteropexy with Sacrospinous Ligament Fixation: Uterine preservation via vaginal route; bilateral or unilateral cervical fixation to sacrospinous ligament
SURGICAL PROCEDURES — Advanced Minimally Invasive & Robotic-Assisted:
• Robotic-Assisted Sacrocolpopexy (da Vinci Xi System): Considered the gold standard for apical vault suspension post-hysterectomy; Y-shaped polypropylene mesh placed from the vaginal apex to the sacral promontory under 3D magnified vision; robotic articulation allows precise retroperitoneal dissection with <100 mL blood loss, <1% conversion to open, and same-day or 23-hour discharge in fit patients; objective cure rate 90–95% at 2 years (FDA-cleared, peer-reviewed data from CLASS and SCARP trials)
• Laparoscopic Sacrocolpopexy: Equivalent anatomical outcomes to robotic approach; lower equipment cost; technically demanding; widely performed at high-volume Indian and UAE centres
• Total Laparoscopic Hysterectomy (TLH) + Laparoscopic Sacrocolpopexy: Combined approach for women with uterus requiring removal and significant apical prolapse; single-anaesthetic efficiency
• Laparoscopic Burch Colposuspension or Mid-Urethral Sling (TVT / TOT): Concurrent anti-incontinence procedures performed at the same operative setting if urodynamics confirm stress urinary incontinence
MATERIALS & IMPLANT DECISIONS:
• Type 1 macroporous monofilament polypropylene mesh (e.g., Gynemesh, Restorelle): preferred for abdominal/laparoscopic/robotic sacrocolpopexy; excellent tissue incorporation; distinct from transvaginal mesh (restricted in many countries)
• Biological grafts (porcine dermis, cadaveric fascia lata): considered in mesh-sensitised patients or post-radiation fields
• Native tissue only: preferred for vaginal hysterectomy + suspension in standard-risk patients without prior repair failure
ANAESTHESIA:
• General anaesthesia (GA) with endotracheal intubation: standard for laparoscopic/robotic procedures (Trendelenburg positioning)
• Combined spinal-epidural (CSE): preferred for vaginal hysterectomy and vaginal repairs; allows epidural patient-controlled analgesia (PCA) post-operatively
• Enhanced Recovery After Surgery (ERAS) protocol: pre-operative carbohydrate loading, opioid-sparing multimodal analgesia (paracetamol, NSAIDs, dexamethasone, local infiltration), early mobilisation within 6 hours of surgery
Cost of Uterine Prolapse Surgery: India vs. UAE
The total cost of uterine prolapse surgery varies significantly depending on the chosen destination, the specific surgical approach, the requirement for concurrent procedures (anterior/posterior repair, anti-incontinence surgery), and the grade of hospital accommodation. India offers internationally equivalent surgical expertise at 40–60% lower cost than the UAE, driven by lower hospital infrastructure costs and surgical fees. The UAE, particularly Dubai and Abu Dhabi, commands a premium for its luxury hospital environment, geographic accessibility from Europe and the GCC, and seamless international insurance acceptance. Both destinations offer NABH/JCI (India) and JCI/DHA (UAE) accreditation as quality benchmarks. The cost ranges below reflect standard packages at accredited hospitals coordinated through GAF Healthcare and include the core surgical episode; ancillary services (physiotherapy, extended LMWH, mesh implant costs, and multi-compartment concurrent repair) may incur additional fees disclosed upfront in the GAF personalised quote.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $2,500 – $6,000 | ~57% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $6,000 – $14,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — REMOTE PRE-CONSULTATION (Weeks 1–4 Before Travel):
• Step 1: GAF Healthcare coordinator receives patient inquiry; shares a standardised Gynaecology Intake Questionnaire covering POP-Q staging reports, urodynamics results, MRI/ultrasound findings, obstetric and surgical history, and current medications
• Step 2: Medical records reviewed by GAF's in-house clinical advisory team; shortlisted urogynecologist profiles and hospital options shared with patient within 48 hours
• Step 3: Teleconsultation with chosen surgeon (Zoom/Teams); surgeon reviews imaging, discusses procedure selection (e.g., robotic sacrocolpopexy vs. vaginal hysterectomy + USLS), confirms candidacy, and provides a written Treatment Plan with itemised cost estimate
• Step 4: GAF Healthcare assists with e-Medical Visa application for India (typically approved in 3–5 business days) or visit/medical visa for UAE; flight and accommodation recommendations provided
PHASE 2 — PRE-OPERATIVE IN-COUNTRY (Days 1–3 After Arrival):
• Day 1: Airport pickup by GAF coordinator; hotel check-in; rest
• Day 2: Hospital admission for pre-operative workup — repeat examination under anaesthesia (EUA) by surgeon if needed; urodynamics (if not done remotely); blood tests (CBC, coagulation, metabolic panel, group and screen); ECG; anaesthesia fitness assessment; consent process (informed consent with visual aids and translator if needed); bowel preparation per ERAS protocol
• Day 3 (day before surgery): Nil by mouth from midnight; compression stockings fitted; low-molecular-weight heparin (LMWH, e.g., enoxaparin 40 mg SC) administered for DVT prophylaxis; pre-operative anxiolytic if required
PHASE 3 — THE OPERATIVE DAY:
• Patient arrives in theatre at 07:00–08:00; regional or general anaesthesia induced
• Robotic/laparoscopic procedure: 4–6 trocar ports placed; 90–120 minutes operative time for sacrocolpopexy; intraoperative cystoscopy performed routinely to confirm ureteric patency after mesh placement; estimated blood loss typically 50–150 mL
• Vaginal hysterectomy + suspension: 60–90 minutes; performed in dorsal lithotomy position; concurrent anterior/posterior repair added as indicated
• Recovery room: 1–2 hours monitoring; patient awake and alert; IV paracetamol and ketorolac for pain control; urinary catheter in situ
• Transfer to ward: same day
PHASE 4 — IN-HOSPITAL RECOVERY (Days 1–4 Post-Op):
• Day 1 post-op: Mobilisation within 6 hours (ERAS); clear fluids; urinary catheter removed at 24 hours (robotic/laparoscopic) or 24–48 hours (vaginal); trial of void with bladder scan; oral analgesia commenced
• Day 2: Soft diet; wound inspection; prophylactic LMWH continued; physiotherapy review; pelvic floor precautions counselling (no lifting >2 kg; no straining; constipation prevention with lactulose or macrogol)
• Day 3–4: Discharge planning; written post-operative instructions; prescription for 2-week course of vaginal oestrogen (post-menopausal patients); 10-day course of prophylactic antibiotics (trimethoprim or cefalexin); LMWH prescription for extended outpatient DVT prophylaxis (28 days for high-risk patients)
• Discharge criteria: Independent mobilisation, adequate oral intake, voiding normally, pain controlled on oral analgesia, no signs of infection or haematoma
PHASE 5 — POST-DISCHARGE IN-COUNTRY RECOVERY (Weeks 1–4):
• Week 1: Rest at hotel/serviced apartment; GAF coordinator performs daily WhatsApp welfare check; wound dressing change at hotel or local clinic arranged by GAF; ice pack and oral NSAIDs for perineal discomfort
• Week 2: Outpatient follow-up with surgeon: wound inspection, vaginal vault check (speculum examination), catheter removal if suprapubic catheter placed; review of voiding diary; staple/suture removal if applicable
• Week 3: For minimally invasive procedures — surgeon clears patient for short-haul flight (<4 hours) with bilateral compression stockings, adequate hydration, and aspirin 75 mg if not contraindicated; LMWH continued until day of travel (high-risk patients)
• Week 4–6: For open or complex procedures — final surgical review; fit-to-fly certificate issued by surgeon; GAF coordinator arranges airport assistance and wheelchair service
PHASE 6 — LONG-TERM RECOVERY AT HOME (Months 1–6):
• 4–6 weeks: Pelvic rest (no sexual intercourse, no tampons, no intravaginal devices); avoid lifting >5 kg; return to desk work/light activity at 4–6 weeks
• 6–8 weeks: Driving permitted once off opioid analgesia and able to perform emergency stop safely
• 3 months: Supervised pelvic floor physiotherapy commenced (biofeedback and progressive resistance exercises); return to low-impact exercise (walking, swimming)
• 6 months: High-impact activity (running, aerobics) and heavy lifting (>10 kg) permitted after physiotherapy clearance; formal surgeon review (teleconsultation with GAF Healthcare via treating surgeon)
• 12 months: Standardised PGI-I (Patient Global Impression of Improvement) and PFDI-20 (Pelvic Floor Distress Inventory) symptom questionnaires administered to assess surgical outcome; long-term vaginal oestrogen maintenance in post-menopausal women
Risks & Considerations
Uterine prolapse surgery, while generally safe in accredited high-volume centres, carries procedure-specific and patient-specific risks that patients must understand before travel. Intraoperative risks include inadvertent cystotomy (bladder injury, incidence ~1–2% in laparoscopic/robotic sacrocolpopexy, managed by immediate intraoperative repair), ureteric injury (<0.5%, detected by routine intraoperative cystoscopy with indigo carmine dye), bowel injury (<0.5%, higher risk in patients with prior abdominal surgery and adhesions), and haemorrhage requiring transfusion (<1%). Post-operative complications include urinary tract infection (most common, ~10–15%; mitigated by perioperative catheter care protocols and prophylactic antibiotics), voiding dysfunction or urinary retention (5–10%; usually transient, managed with clean intermittent self-catheterisation for 1–4 weeks), de novo urgency urinary incontinence (5–15%; treated with antimuscarinics such as solifenacin or mirabegron), wound haematoma or vaginal vault haematoma (<3%), and mesh-related complications specific to sacrocolpopexy (mesh exposure/erosion 2–5% at 5 years; pelvic pain; dyspareunia — risk minimised by Type 1 macroporous mesh, meticulous surgical technique, and post-operative vaginal oestrogen in post-menopausal patients). Prolapse recurrence remains the most clinically significant long-term risk: native-tissue vaginal repairs carry a 10–30% anatomical recurrence rate at 5 years (OPTIMAL trial data); robotic/laparoscopic sacrocolpopexy has lower recurrence (~10–15% at 5–7 years). Deep vein thrombosis and pulmonary embolism risk is elevated in pelvic surgery, particularly in patients with Caprini Score ≥3; GAF Healthcare hospitals apply NICE/ACOG-compliant thromboprophylaxis protocols (LMWH + pneumatic compression devices). Patients with obesity (BMI >35), prior pelvic radiation, diabetes, or immunosuppression carry higher complication risk and are counselled accordingly during the pre-operative teleconsultation. The fit-to-fly window of 3–6 weeks is specifically designed to clear the period of highest DVT risk and ensure wound integrity before pressurised cabin travel.
Top Hospitals for Uterine Prolapse Surgery
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Aster Hospital Dubai
Dubai, UAE
Top Doctors for Uterine Prolapse Surgery
Internationally trained specialists in Gynecology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Tarang Preet Kaur
MBBS, MS, MRCOG, MCh, Fellowship in Urogynaecology, Fellowship in Cosmetic Gynaecology
Urogynaecologist
Max Super Speciality Hospital, Saket, New Delhi, India
11+ Yearsof experience
Dr. Tarang Preet Kaur is a Consultant in Urogynaecology with over 11 years of clinical experience, currently practicing at Max Super Speciality Hospital, Saket in New Delhi. She holds an MCh in Urogynaecology from Edge Hill University, United Kingdom (2024), the MRCOG from the Royal College of Obstetricians & Gynaecologists, and an MS in Obstetrics & Gynaecology from Maulana Azad Medical College, Delhi. Her dual qualification across India and the UK… Read more
Dr. Amrinder Kaur Bajaj
MBBS, MD — Obstetrics & Gynaecology (Gold Medalist), Senior Residency — Obstetrics & Gynaecology, FRSH — Fellow of the Royal Society of Health, FIAMS — Fellow of the Indian Association of Medical Specialists
Obstetrician & Gynaecologist
Fortis Hospital, Gurgaon, Gurgaon, India
42+ Yearsof experience
Dr. Amrinder Kaur Bajaj is one of Delhi-NCR's most experienced gynaecologists, with over four decades spent caring for women at every stage of life. She currently practises as a Consultant in Obstetrics & Gynaecology at Fortis Hospital, Gurgaon, where she brings together deep clinical knowledge and a quietly reassuring bedside manner that patients — and their families — find genuinely comforting. Her academic journey set a high bar early on. She completed… Read more
Dr. Anuradha Khurana
MBBS, DGO (Diploma in Obstetrics & Gynaecology), PG in High Risk Pregnancy and Infertility
Gynecologist & Obstetrics Specialist
Artemis Hospital, New Delhi, India
20+ Yearsof experience
Dr. Anuradha Khurana is a Senior Consultant in Obstetrics and Gynecology at Artemis Hospital, Delhi, with over two decades of hands-on experience in women's health. She is particularly well regarded for her work in high-risk pregnancy management, uterine conditions like fibroids and endometriosis, and complex gynecological surgeries. Patients and families consistently describe her as someone who takes the time to truly listen — and to explain things in a… Read more
Dr. Aswari Kesari Kapoor
MBBS, DGO (Diploma in Gynaecology & Obstetrics), CPS (College of Physicians and Surgeons), DNB (Diplomate of National Board) — Obstetrics & Gynaecology
Obstetrician & Gynecologist
Indraprastha Apollo Hospital, New Delhi, India
23+ Yearsof experience
Dr. Aswari Kesari Kapoor is a seasoned Obstetrician and Gynecologist with over 23 years of hands-on clinical experience. She practices at Indraprastha Apollo Hospital in New Delhi — one of India's most respected multi-specialty institutions. Over the course of her career, she has built a strong reputation for managing complex gynecological conditions alongside high-risk pregnancies, all with a calm and reassuring bedside manner that patients consistently… Read more
Dr. Bindhu K S
MBBS, DNB (Obstetrics & Gynecology), Fellowship in Minimal Access Surgery, FICOG (Fellowship of the Indian College of Obstetricians and Gynaecologists), Certificate in Gynecologic and Obstetric Sonography, Certificate in Appreciation of Well Being in Fetal Heart Disease
Obstetrician & Gynecologist
Apollo Hospitals, Navi Mumbai, Mumbai, India
23+ Yearsof experience
Dr. Bindhu K S is a seasoned Obstetrician and Gynecologist based in Mumbai, currently practicing at Apollo Hospitals, Navi Mumbai. With over two decades of clinical experience, she brings together expertise in both obstetrics and advanced minimally invasive gynecologic surgery. Whether a patient comes with a complex fibroid, troublesome endometriosis, or a high-risk pregnancy, Dr. Bindhu approaches each situation with careful thought and genuine care. Her… Read more
Frequently Asked Questions — Uterine Prolapse Surgery
The cost of uterine prolapse surgery in India typically ranges from USD 2,500 to USD 6,000 for the complete surgical episode, encompassing surgeon fees, hospital stay (2–5 days), anaesthesia, operating theatre charges, standard medications, and routine post-operative follow-up at NABH- and JCI-accredited hospitals. This range covers the full spectrum from vaginal hysterectomy with native-tissue vault suspension at the lower end to robotic-assisted sacrocolpopexy (da Vinci Xi) with concurrent anterior and posterior compartment repair at the higher end. In the UAE (Dubai or Abu Dhabi), the equivalent procedure at JCI- and DHA-licensed centres costs between USD 6,000 and USD 14,000, reflecting higher hospital infrastructure costs, premium accommodation standards, and international specialist fees. India is therefore approximately 50–60% less expensive than the UAE for equivalent surgical quality. Additional costs to budget for in both destinations include diagnostic workup on arrival (if not completed remotely), implant/mesh costs for robotic sacrocolpopexy (can add USD 300–800 in India; USD 800–2,000 in UAE), extended DVT prophylaxis (LMWH), physiotherapy sessions, and accommodation for an accompanying attendant. GAF Healthcare provides a fully itemised, fixed-price quote for each patient after reviewing medical records — eliminating hidden billing surprises. Patients with international health insurance should note that many UAE partner hospitals are direct-billing providers for major insurers (Cigna, Bupa, AXA), which may further reduce out-of-pocket costs in the UAE.
The minimum recommended in-country stay before international air travel depends on the specific surgical approach and each patient's individual recovery trajectory, and is confirmed in writing by the treating surgeon before you depart. As a general guide: patients who undergo minimally invasive laparoscopic or robotic-assisted sacrocolpopexy require a minimum of 3 weeks in-country (2–3 days in hospital + approximately 18 days recuperation), after which the surgeon may issue fit-to-fly clearance for short-haul flights under 4 hours. For medium- to long-haul international flights (4–10+ hours), a 4–5 week post-operative stay is preferred to ensure complete healing of the mesh fixation sutures, resolution of any voiding dysfunction, and passage of the highest-risk DVT window. Patients who undergo vaginal hysterectomy with concurrent anterior/posterior repair require 3–4 weeks in-country for vaginal vault healing before pressurised cabin travel. Patients who undergo open abdominal sacrocolpopexy or complex combined procedures should plan for 5–6 weeks. All GAF Healthcare patients travelling by air must wear bilateral graduated compression stockings (18–23 mmHg) throughout the flight, remain well-hydrated, perform hourly in-seat ankle exercises, and — if prescribed by their surgeon — take low-dose aspirin or a final dose of LMWH on the day of travel. A formal Fit-to-Fly Medical Certificate, accepted by airlines, is issued by the treating hospital and provided to every GAF Healthcare patient before departure.
The success rate of uterine prolapse surgery varies by procedure type, definition of success, and length of follow-up, but overall, 85–95% of patients achieve satisfactory anatomical and symptomatic outcomes at 1–2 years post-operatively in high-volume accredited centres. Robotic-assisted and laparoscopic sacrocolpopexy — the benchmark apical suspension procedure — demonstrate objective anatomical cure rates of 90–95% at 2 years and approximately 85–88% at 5–7 years (SCARP and eVAULT trial data). Native-tissue vaginal repairs including uterosacral ligament suspension and sacrospinous ligament fixation achieve equivalent short-term outcomes (~85–90% at 1 year) but carry higher anatomical recurrence rates of 15–30% beyond 5 years compared to mesh-augmented abdominal repairs (OPTIMAL trial). The obliterative colpocleisis procedure carries the highest success rate of all (>95% at 5 years) but is reserved for elderly patients who are sexually inactive. Subjective success — defined as patient-reported resolution of bothersome bulge symptoms and improvement in bladder and bowel function — is consistently high (88–93%) across all techniques in experienced hands, as measured by validated tools such as the PFDI-20 and PGI-I questionnaires. The key determinants of long-term success include surgeon experience and annual caseload (centres performing >100 prolapse repairs annually show statistically superior outcomes), correct procedure selection for the patient's specific defect pattern, concurrent pelvic floor physiotherapy post-operatively, and sustained long-term vaginal oestrogen use in post-menopausal women. GAF Healthcare partner hospitals are selected precisely on the basis of high surgical volume, formal urogynecology fellowship training of operating surgeons, and prospective outcome tracking — ensuring patients access care at the top decile of global surgical quality.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides a fully integrated medical tourism coordination service covering every non-clinical aspect of the patient journey for both India and the UAE.
INDIA — VISA & ENTRY: GAF Healthcare facilitates the Indian e-Medical Visa (e-MV) application online through the Indian government portal (indianvisaonline.gov.in). The e-Medical Visa allows a 60-day stay (triple entry) and is typically approved within 3–5 business days upon submission of a GAF Healthcare-issued hospital invitation letter, passport copy, and bank statement. An accompanying attendant (spouse, family member) qualifies for an e-Medical Attendant Visa simultaneously. GAF's documentation team prepares all supporting letters and guides patients through the online form step-by-step. Extended stays beyond 60 days can be converted to a regular medical visa at the Foreigners Regional Registration Office (FRRO) with GAF's assistance.
UAE — VISA & ENTRY: Passport holders from the GCC, EU, USA, UK, Canada, Australia, and most Asian countries receive visa-free access or a visa-on-arrival for up to 30–90 days depending on nationality. Patients from countries requiring advance visas are supported by GAF Healthcare with a UAE Medical/Visit Visa application facilitated through the hospital sponsor. The Dubai Health Authority (DHA) and Department of Health Abu Dhabi (DoH) regulate all licensed medical facilities, and GAF's UAE partner hospitals can issue official treatment letters to expedite visa approval.
AIRPORT TRANSFERS: Dedicated GAF Healthcare ground transport is arranged for all arrival and departure transfers — air-conditioned private car or accessible medical van depending on patient mobility requirements. For post-operative transfers, a vehicle with reclining seating and step-free access is arranged. All drivers are briefed on the patient's post-surgical status.
HOSPITAL COORDINATION: GAF's in-country coordinator accompanies the patient to all hospital appointments: pre-operative assessment, surgery day, and follow-up visits. The coordinator manages appointment scheduling, insurance paperwork, and real-time communication between the patient and medical team. A digital Patient Dashboard (WhatsApp-based with daily check-ins) ensures 24/7 access to GAF support throughout the stay.
TRANSLATION SERVICES: Certified medical translators are available for major languages including Arabic, Russian, French, Bangla, and Kiswahili at all partner hospitals in India and the UAE. Remote interpretation via video link is arranged for less common languages. All consent documents, discharge summaries, and prescription instructions are translated into the patient's preferred language before departure.
ATTENDANT ACCOMMODATION: GAF Healthcare negotiates preferential rates at serviced apartments and hotels within 5–15 minutes of partner hospitals. Options range from budget-conscious ($35–60/night near Indian hospitals) to premium serviced residences near UAE facilities ($120–250/night). For patients requiring extended stays (post-operative recovery), GAF arranges month-rate furnished apartments with cooking facilities, enabling cost-effective recovery. Hospital in-room attendant cots are arranged at no extra cost for the accompanying family member during the inpatient stay.
POST-DISCHARGE FOLLOW-UP: All patients receive a structured Teleconsultation Follow-Up Plan through GAF Healthcare: video consultations with the treating surgeon at 2 weeks, 6 weeks, and 3 months post-operatively. Medical records, surgical reports, histopathology results (if applicable), and discharge summaries are digitised and shared via the GAF Healthcare secure patient portal within 48 hours of discharge for continuity of care with the patient's home country physician.